Acute Basophilic Leukemia Arising from Chronic Myeloid Leukemia with +8, I(17q)(q10) and der(22)t(9;22) After Imatinib Therapy

Acute Basophilic Leukemia Arising from Chronic Myeloid Leukemia with +8, I(17q)(q10) and der(22)t(9;22) After Imatinib Therapy

Peng Shan,1,2 Hang Dong,1,2 Shilan Li3 1Department of Laboratory, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230036, People’s Republic of China; 2Core Unit of National Clinical Research Center for Labora...

Full description

Bibliographic Details
Main Authors:	Shan P, Dong H, Li S
Format:	Article
Language:	English
Published:	Dove Medical Press 2023-09-01
Series:	Journal of Blood Medicine
Subjects:	cml tkis mcs abl complex karyotype
Online Access:	https://www.dovepress.com/acute-basophilic-leukemia-arising-from-chronic-myeloid-leukemia-with-8-peer-reviewed-fulltext-article-JBM

Similar Items

CD26/DPP-4 in Chronic Myeloid Leukemia
by: Anna Sicuranza, et al.
Published: (2022-02-01)

Stem Cell Responsiveness to Imatinib in Chronic Myeloid Leukemia
by: Rachid Lahlil, et al.
Published: (2023-11-01)

Influence of late treatment on how chronic myeloid leukemia responds to imatinib
by: Ana Carolina Costa Scerni, et al.
Published: (2009-01-01)

Monitoração molecular da Leucemia Mielóide Crônica na era do imatinibe Molecular monitoring of Chronic Myeloid Leukemia in the imatinib era
by: Israel Bendit
Published: (2008-04-01)

Effect of Plumbagin on growth inhibition and apoptosis of imatinib-resistant chronic myeloid leukemia
by: Bui Thi Kim Ly, et al.
Published: (2017-08-01)

DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA
by: Buket Altinok Gunes, et al.
Published: (2023-01-01)

Frequency of BCR-ABL Fusion Transcript in Iranian Patients with Chronic Myeloid Leukemia
by: M Yaghmaie, et al.
Published: (2005-09-01)

Frequency of BCR-ABL Fusion Transcript in Iranian Patients with Chronic Myeloid Leukemia
by: Yaghmaie M., et al.
Published: (2005-09-01)

Genotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment
by: Monika Jaruskova, et al.
Published: (2017-04-01)

Tyrosine Kinase Inhibitors Play an Antiviral Action in Patients Affected by Chronic Myeloid Leukemia: A Possible Model Supporting Their Use in the Fight Against SARS-CoV-2
by: Sara Galimberti, et al.
Published: (2020-09-01)

Effects of ABCG2 C421A and ABCG2 G34A genetic polymorphisms on clinical outcome and response to imatinib mesylate, in Iranian chronic myeloid leukemia patients
by: Negar Nouri, et al.
Published: (2023-01-01)

HHV8-Negative Effusion-Based Large B Cell Lymphoma Arising in Chronic Myeloid Leukemia Patients under Dasatinib Treatment: A Report of Two Cases
by: Stefano Fiori, et al.
Published: (2021-02-01)

Philadelphia Chromosome-Positive Leukemia in the Lymphoid Lineage—Similarities and Differences with the Myeloid Lineage and Specific Vulnerabilities
by: Lukasz Komorowski, et al.
Published: (2020-08-01)

Identification of CD203c as a New Basophil-Specific Flow-Marker in Ph<sup>+</sup> Chronic Myeloid Leukemia
by: Irina Sadovnik, et al.
Published: (2022-12-01)

Chronic Myeloid Leukaemia with isolated massive thrombocytosis and BCR‐ABL1 detection failure using RT‐MLPA (positive RT‐qPCR)
by: Lucie Coster, et al.
Published: (2021-08-01)

Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia
by: Michele Massimino, et al.
Published: (2018-02-01)

Chronic Myeloid Leukemia and Pregnancy: When Dreams Meet Reality. State of the Art, Management and Outcome of 41 Cases, Nilotinib Placental Transfer
by: Elisabetta Abruzzese, et al.
Published: (2022-03-01)

A case of chronic myelogenous leukemia in pregnancy characterized by a complex translocation t(9;22;11)(q34;q11.2;q13)
by: Surachit Kumar, et al.
Published: (2011-11-01)

The Downregulation of Both Giant HERCs, <i>HERC1</i> and <i>HERC2</i>, Is an Unambiguous Feature of Chronic Myeloid Leukemia, and HERC1 Levels Are Associated with Leukemic Cell Differentiation
by: Muhammad Shahzad Ali, et al.
Published: (2022-01-01)

Molecular Pathogenesis and Treatment Strategies of Chronic Myeloid Leukemia (CML)
by: Rabia Khalid, et al.
Published: (2023-12-01)

Association of BCR/ABL transcript variants with different blood parameters and demographic features in Iraqi chronic myeloid leukemia patients
by: Mahmood S. Khazaal, et al.
Published: (2019-08-01)

A novel five-way translocation t(7;11;9;22;<ul>9</ul>)(q22;q13;q34;q11.2;q34) involving Ph chromosome in a patient of chronic myeloid leukemia: a case report
by: Yokota Sho, et al.
Published: (2012-05-01)

Inhibition of Xanthine Oxidoreductase Enhances the Potential of Tyrosine Kinase Inhibitors against Chronic Myeloid Leukemia
by: Marta Romo-González, et al.
Published: (2020-01-01)

Evaluation of Imatinib adherence in chronic myeloid leukemia patients in Babylon Province, Iraq
by: Athmar Kadhim Gatea, et al.
Published: (2023-01-01)

Fusion gene bcr-abl: From etiopathogenesis to the management of chronic myeloid leukemia
by: Tri Agusti Sholikah
Published: (2017-04-01)

Methylenetetrahydrofolate Reductase Gene C677T and A1298C Polymorphic Sequence Variations Influences the Susceptibility to Chronic Myeloid Leukemia in Kashmiri Population
by: Shahid M. Baba, et al.
Published: (2019-07-01)

Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line
by: Anna Kreutzman, et al.
Published: (2019-09-01)

Imatinib en leucemia mieloide crónica Imatinib in chronic myeloid leukemia
by: Valia Pavón Morán, et al.
Published: (2005-12-01)

Future Approaches for Treating Chronic Myeloid Leukemia: CRISPR Therapy
by: Elena Vuelta, et al.
Published: (2021-02-01)

A Study on BCR-ABL Kinase Domain Mutations in Chronic Myeloid Leukemia from Western India
by: Pankaj Gadhia, et al.
Published: (2021-10-01)

Acquisition of mixed lineage leukemia rearrangement in a chronic myeloid leukemia patient while on imatinib
by: Adriana Zámečníkova
Published: (2011-08-01)

Saudi Arabian CML patient with a novel four‐way translocation at t(9;22;5;2)(q34;q11.2;p13;q44)
by: Walid Dridi, et al.
Published: (2022-06-01)

Management of chronic myeloid leukaemia: current treatment options, challenges, and future strategies
by: Salma Younes, et al.
Published: (2023-12-01)

The molecular mechanisms underlying BCR/ABL degradation in chronic myeloid leukemia cells promoted by Beclin1-mediated autophagy
by: Huang X, et al.
Published: (2019-06-01)

Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 Transcripts
by: Michele Massimino, et al.
Published: (2021-06-01)

Atypical chronic myeloid leukemia with t(9;22)(p24,11.2), a BCR-JAK2 fusion gene
by: Marcelo Bellesso, et al.
Published: (2013-06-01)

Mechanistic Insights Into Co-Administration of Allosteric and Orthosteric Drugs to Overcome Drug-Resistance in T315I BCR-ABL1
by: Hao Zhang, et al.
Published: (2022-03-01)

De novo acute megakaryoblastic leukemia with p210 BCR/ABL and t(1;16) translocation but not t(9;22) Ph chromosome
by: Min Xiao, et al.
Published: (2011-11-01)

<i>ABL</i> Genomic Editing Sufficiently Abolishes Oncogenesis of Human Chronic Myeloid Leukemia Cells In Vitro and In Vivo
by: Shu-Huey Chen, et al.
Published: (2020-05-01)

SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection
by: Elisabetta Abruzzese, et al.
Published: (2020-04-01)